A certificate under section 86J(6) of the Act must, in addition to a statement as to the presence of a drug in that sample of oral fluid, contain the following particulars—
(a) a statement by the approved analyst that the analyst is an approved analyst within the meaning of section 86J(1) of the Act;
(b) a statement as to the method of analysis used;
(c) the name and signature of the approved analyst;
(d) the date on which the analysis was conducted;
(e) a description of the contents of the identification label referred to in regulation 17 that was attached to the part of the oral fluid received for analysis.